US stocks surged overnight, with the Nasdaq Composite closing above 20,000 for the first time. Latest US CPI data boosts rate cut expectations.

Immutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at the ESMO Immuno-Oncology Congress 2024.

US inflation rose to an annual rate of 2.7% in November, up from 2.6% in October, according to Consumer Price Index (CPI) data released on Wednesday by the Bureau of Labor Statistics. The monthly ...

INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and ...

Shares in Alphabet (NASDAQ: GOOGL) rose more than 5% on Tuesday after the company announced the development of its new ...

Perpetual (ASX:PPT) has provided an update on its proposed scheme of arrangement with KKR, revealing that tax complications ...

Integral Diagnostics (ASX:IDX) has secured clearance from the ACCC for its proposed acquisition of Capitol Health (ASX:CAJ).

BrainChip (ASX:BRN) has been awarded a US$1.8m contract with the US Air Force Research Laboratory (AFRL) to develop ...

Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy ...

China's Communist Party has shifted its monetary policy stance to 'moderately loose' from 'prudent' for the first time since ...

US stocks have closed lower, with the Dow Jones Industrial Average down for the fourth consecutive session. The Dow shed 154.10 points, or 0.35%, to close at 44,247.83. The S&P 500 dropped 0.3% to ...

At its December meeting the RBA left the cash rate on hold at 4.35% as widely expected, leaving it unchanged for 13 months ...